Getinge AB (MIL:1GETI) Other Long-Term Liabilities: €256 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MIL:1GETI Getinge AB MIL:1GETI
51 GF Score
Price €20.90
GF Value €17.80
Valuation Modestly Overvalued
! 10 Warning Signs
View Full Analysis

What is Getinge AB Other Long-Term Liabilities?

Getinge AB MIL:1GETI 51 Other Long-Term Liabilities is €256 Mil as of Jun. 2026. GuruFocus rates MIL:1GETI with a GF Score™ of 51/100 and a GF Value™ of €17.80 (Modestly Overvalued). The stock has 10 warning signs investors should review.

Getinge AB's other long-term liabilities for the quarter that ended in Jun. 2026 was €256 Mil.

Getinge AB's quarterly other long-term liabilities increased from Dec. 2025 (€242 Mil) to Mar. 2026 (€255 Mil) and increased from Mar. 2026 (€255 Mil) to Jun. 2026 (€256 Mil).

Getinge AB's annual other long-term liabilities increased from Dec. 2023 (€202 Mil) to Dec. 2024 (€399 Mil) but then declined from Dec. 2024 (€399 Mil) to Dec. 2025 (€242 Mil).

Getinge AB Other Long-Term Liabilities Related Terms

Getinge AB Other Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for Getinge AB's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Getinge AB Other Long-Term Liabilities Chart

Getinge AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 167.56 178.01 201.50 399.47 241.68

Getinge AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 274.68 274.07 241.68 255.12 256.05
MIL:1GETI
51GF Score
Getinge AB MIL:1GETI
Other Long-Term Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Getinge AB Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

What does a Other Long-Term Liabilities of €256 Mil mean?
Getinge AB (MIL:1GETI) has a Other Long-Term Liabilities of €256 Mil as of Jun. 2026. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Getinge AB and its competitors.
Is Getinge AB's Other Long-Term Liabilities too high?
Getinge AB's current Other Long-Term Liabilities is €256 Mil. Overall, Getinge AB has a GF Score™ of 51/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Getinge AB's Other Long-Term Liabilities compare to ABT and SYK?
Getinge AB's Other Long-Term Liabilities of €256 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for a Medical Devices & Instruments company?
A good Other Long-Term Liabilities depends on the Medical Devices & Instruments industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Getinge AB and its competitors. Getinge AB's current Other Long-Term Liabilities is €256 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Getinge AB stock overvalued right now?
Based on GuruFocus' analysis, Getinge AB (MIL:1GETI) is currently considered Modestly Overvalued. The stock's GF Value™ is €17.80, compared to a current price of €20.90 — trading 17.4% above its estimated fair value. The current Other Long-Term Liabilities is €256 Mil. Getinge AB's overall GF Score™ is 51/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For Getinge AB (MIL:1GETI), the current Other Long-Term Liabilities is €256 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Getinge AB (MIL:1GETI) Overvalued in 2026?

Based on GuruFocus' analysis, Getinge AB stock appears to be overvalued. The current stock price of €20.90 is trading 17.4% above its estimated GF Value™ of €17.80. GuruFocus considers Getinge AB to be Modestly Overvalued.

Key valuation signals for MIL:1GETI:

  • Other Long-Term Liabilities: €256 Mil
  • GF Value™: €17.80 vs. price of €20.90 (17.4% above fair value)
  • GF Score™: 51/100 with 10 warning signs

No single metric tells the full story. See the MIL:1GETI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Getinge AB Business Description

Address Lindholmspiren 7A, P.O. Box 8861, Gothenburg, SWE, 417 56
Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings. The company reports in three segments: acute care therapies (52% of revenue), surgical workflows (35%), and life sciences (13%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems. Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 45% of sales, Europe, Middle East, and Africa 35%, and Asia-Pacific the remaining 25%.
51GF Score

Get the complete analysis for MIL:1GETI

Other Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€20.90
Price
€17.80
GF Value